Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.
Industry · 17 registered clinical trials.
Status
Trial
Phase
Started
Terminated
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
Adolescent Lupus Nephritis, Pediatric Lupus Nephritis
Phase 3
2024-03-28
Terminated
Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis
Adolescent Lupus Nephritis, Pediatric Lupus Nephritis
Phase 3
2023-10-10
Completed
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
Lupus Nephritis
—
2022-04-05
Completed
Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin
Drug-drug Interaction
Phase 1
2022-01-24
Completed
Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry E
Dry Eye Syndrome, Keratoconjunctivitis Sicca
Phase 2 / Phase 3
2019-10-14
Completed
Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin
Lupus Nephritis
Phase 3
2019-09-29
Completed
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
Dry Eye
Phase 2
2018-08-13
Terminated
Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulos
Focal Segmental Glomerulosclerosis
Phase 2
2018-06-21
Completed
Aurinia Renal Response in Active Lupus With Voclosporin
Lupus Nephritis
Phase 3
2017-05-17
Completed
Voclosporin in Healthy Japanese Volunteers
Volunteers
Phase 1
2016-10-01
Completed
Aurinia Early Urinary Protein Reduction Predicts Response
Lupus Nephritis
Phase 2
2015-06-01
Completed
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
Lupus Nephritis
Phase 2
2014-06-01
Withdrawn
Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation
Renal Transplantation
Phase 3
2013-03-01
Completed
Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
Psoriasis
Phase 3
2006-12-01
Completed
Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
Kidney Diseases
Phase 2
2006-01-01
Completed
A 36-Week Extension to Protocol ISA04-03
Psoriasis
Phase 3
2005-09-01
Completed
Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis
Psoriasis
Phase 3
2004-12-01